Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Therapeutic Innovation & Regulatory Science|July 20, 2019
Awareness and Collaboration Across Stakeholder Groups Important for eConsent Achieving Value-Driven AdoptionHilde Vanaken, Shirley N MasandJournal of Neurotrauma|April 9, 2011
Microfluidic generation of haptotactic gradients through 3D collagen gels for enhanced neurite growthHarini G Sundararaghavan, Shirley N Masand, David I ShreiberBiomedical Microdevices|June 29, 2011
Nanoporous membrane-sealed microfluidic devices for improved cell viabilityShirley N Masand, Lindsay Mignone, Jeffrey D Zahn, et al.Biomaterials|October 27, 2011
Neural cell type-specific responses to glycomimetic functionalized collagenShirley N Masand, Isaac J Perron, Melitta Schachner, et al.Journal of Biomedical Materials Research. Part A|December 23, 2015
Salicylic acid-based poly(anhydride-ester) nerve guidance conduits: Impact of localized drug release on nerve regenerationYong S Lee, Jeremy Griffin, Shirley N Masand, et al.Biomaterials|August 25, 2012
The effect of glycomimetic functionalized collagen on peripheral nerve repairShirley N Masand, Jian Chen, Isaac J Perron, et al.Therapeutic Innovation & Regulatory Science|October 31, 2018
Accelerating Adoption of Patient-Facing Technologies in Clinical Trials: A Pharmaceutical Industry Perspective on Opportunities and ChallengesAshley M Polhemus, Hassan Kadhim, Shelly Barnes, et al.British Journal of Clinical Pharmacology|May 22, 2008
A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-negative volunteersMonika Schöller-Gyüre, Thomas N Kakuda, Goedele De Smedt, et al.Journal of Clinical Pharmacology|January 16, 2008
Pharmacokinetic and pharmacodynamic study of the concomitant administration of methadone and TMC125 in HIV-negative volunteersMonika Schöller-Gyüre, Wim van den Brink, Thomas N Kakuda, et al.Pageof 1